amCentre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Melbourne, VIC, Australia ...
Stanford Medicine researchers and their colleagues found that a new drug, obexelimab, significantly reduces the risk of ...
Eosinophilic AE-COPD is associated with a lower risk for major adverse cardiovascular events (MACE) compared with noneosinophilic AE-COPD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results